Item type |
itemtype_ver1(1) |
公開日 |
2023-12-04 |
タイトル |
|
|
タイトル |
An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile |
|
言語 |
en |
著者 |
Sato, Yoshiki
Deguchi, Shoichi
Norose, Tomoko
Oishi, Takuma
Mitsuya, Koichi
Sugino, Takashi
Akiyama, Yasuto
Nagashima, Takeshi
Urakami, Kenichi
Shimoda, Yuji
Ohshima, Keiichi
Hayashi, Nakamasa
Yamaguchi, Ken
|
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
権利 |
|
|
言語 |
en |
|
権利情報Resource |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
権利情報 |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
gliosarcoma |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
metastasis |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
bevacizumab |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
pathology |
キーワード |
|
|
主題Scheme |
Other |
|
主題 |
whole-genome analysis |
内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Gliosarcoma (GS), a morphological variant of glioblastoma, pathologically shows a biphasic pattern with gliomatous and sarcomatous components. It has been reported that GS has much higher metastatic capacity than glioblastoma. A few reports on the pathology of the extracranial metastasis of GS have shown that metastatic lesions had a sarcomatous component alone or a mixture of gliomatous and sarcomatous ones. Therefore, it is considered that GS tends to disseminate hematogenously due to its mesenchymal sarcomatous component. Herein, we report an autopsy case of GS with multiple extracranial metastases treated by craniotomy, radiotherapy, and bevacizumab. In this case, metastatic lesions at autopsy contained a gliomatous component alone, but no sarcomatous component. In addition, the sarcomatous component disappeared from the intracranial lesion at autopsy after the administration of bevacizumab. In this report, we discuss the clinical course and pathological findings at the initial state, recurrence, and autopsy, including the results of whole-genome analysis. |
|
言語 |
en |
出版者 |
|
|
出版者 |
Nagoya University Graduate School of Medicine, School of Medicine |
|
言語 |
en |
言語 |
|
|
言語 |
eng |
資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
departmental bulletin paper |
出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
ID登録 |
|
|
ID登録 |
10.18999/nagjms.85.4.828 |
|
ID登録タイプ |
JaLC |
関連情報 |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/854.html |
収録物識別子 |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0027-7622 |
収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2186-3326 |
書誌情報 |
en : Nagoya Journal of Medical Science
巻 85,
号 4,
p. 828-835,
発行日 2023-11
|